The  	The  	 DT	O
impact  	impact  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
host  	host  	 NN	O
on  	on  	 IN	O
fungal  	fungal  	 JJ	B-NP
infections  	infections  	 JJ	I-NP
Outcomes  	Outcomes  	 NNS	I-NP
of  	of  	 IN	I-NP
fungal  	fungal  	 JJ	I-NP
infections  	infections  	 NNS	I-NP
in  	in  	 IN	O
immunocompromised  	immunocompromised  	 JJ	B-NP
individuals  	individuals  	 NNS	I-NP
depend  	depend  	 VBP	O
on  	on  	 IN	O
a  	a  	 DT	O
complex  	complex  	 JJ	O
interplay  	interplay  	 NN	O
between  	between  	 IN	O
host  	host  	 NN	O
and  	and  	 CC	O
pathogen  	pathogen  	 JJ	B-NP
factors 	factors 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
treatment  	treatment  	 NN	B-NP
modalities 	modalities 	 NN	I-NP
.  	.  	 .	O
Problems  	Problems  	 NNS	O
occur  	occur  	 VBP	O
when  	when  	 WRB	O
host  	host  	 NN	B-NP
responses  	responses  	 NNS	I-NP
to  	to  	 TO	O
an  	an  	 DT	O
infection  	infection  	 NN	B-NP
are  	are  	 VBP	O
either  	either  	 RB	O
too  	too  	 RB	O
weak  	weak  	 JJ	O
to  	to  	 TO	O
effectively  	effectively  	 RB	O
help  	help  	 VB	O
eradicate  	eradicate  	 VB	O
the  	the  	 DT	O
pathogen 	pathogen 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
when  	when  	 WRB	O
they  	they  	 PRP	O
become  	become  	 VBP	O
too  	too  	 RB	O
strong  	strong  	 JJ	O
and  	and  	 CC	O
are  	are  	 VBP	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
host  	host  	 NN	B-NP
damage  	damage  	 NN	I-NP
rather  	rather  	 RB	O
than  	than  	 IN	O
protection 	protection 	 NN	O
.  	.  	 .	O
Immune  	Immune  	 JJ	B-NP
reconstitution  	reconstitution  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
( 	( 	 -LRB-	O
IRS 	IRS 	 NNP	B-NP
)  	)  	 -RRB-	O
can  	can  	 MD	O
be  	be  	 VB	O
generally  	generally  	 RB	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
restoration  	restoration  	 NN	O
of  	of  	 IN	O
host  	host  	 NN	B-NP
immunity  	immunity  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
previously  	previously  	 RB	O
immunosuppressed  	immunosuppressed  	 JJ	B-NP
patient  	patient  	 NN	I-NP
that  	that  	 WDT	O
becomes  	becomes  	 VBZ	O
dysregulated  	dysregulated  	 VBN	O
and  	and  	 CC	O
overly  	overly  	 RB	O
robust 	robust 	 JJ	O
,  	,  	 ,	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
host  	host  	 NN	B-NP
damage  	damage  	 NN	I-NP
and  	and  	 CC	O
sometimes  	sometimes  	 RB	O
death 	death 	 NN	O
.  	.  	 .	O
IRS  	IRS  	 NNP	B-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
opportunistic  	opportunistic  	 JJ	B-NP
mycoses  	mycoses  	 NN	I-NP
presents  	presents  	 VBZ	O
as  	as  	 RB	O
new  	new  	 JJ	O
or  	or  	 CC	O
worsening  	worsening  	 VBG	O
clinical  	clinical  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
or  	or  	 CC	O
radiographic  	radiographic  	 JJ	B-NP
signs  	signs  	 NNS	I-NP
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
an  	an  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
process  	process  	 NN	I-NP
that  	that  	 WDT	O
occur  	occur  	 VBP	O
during  	during  	 IN	O
receipt  	receipt  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
appropriate  	appropriate  	 JJ	O
antifungal 	antifungal 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
that  	that  	 IN	O
cannot  	cannot  	 RB	O
be  	be  	 VB	O
explained  	explained  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
newly  	newly  	 RB	O
acquired  	acquired  	 VBN	B-NP
infection 	infection 	 NN	I-NP
.  	.  	 .	O
Because  	Because  	 IN	O
there  	there  	 EX	O
are  	are  	 VBP	O
currently  	currently  	 RB	O
no  	no  	 DT	O
established  	established  	 JJ	O
tests  	tests  	 NNS	O
or  	or  	 CC	O
biomarkers  	biomarkers  	 NN	B-NP
for  	for  	 IN	I-NP
IRS 	IRS 	 NNP	I-NP
,  	,  	 ,	O
it  	it  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
distinguish  	distinguish  	 VB	O
from  	from  	 IN	O
progression  	progression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
original  	original  	 JJ	B-NP
infection 	infection 	 NN	I-NP
,  	,  	 ,	O
although  	although  	 IN	O
culture  	culture  	 NN	O
and  	and  	 CC	O
biomarkers  	biomarkers  	 NN	B-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
fungal  	fungal  	 JJ	I-NP
pathogen  	pathogen  	 NN	I-NP
or  	or  	 CC	O
infection  	infection  	 NNS	B-NP
are  	are  	 VBP	O
typically  	typically  	 RB	O
negative  	negative  	 JJ	O
during  	during  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
workup 	workup 	 NN	I-NP
.  	.  	 .	O
IRS  	IRS  	 NNP	B-NP
was  	was  	 VBD	O
originally  	originally  	 RB	O
characterized  	characterized  	 VBN	O
in  	in  	 IN	O
human  	human  	 JJ	O
immunodeficiency  	immunodeficiency  	 JJ	B-NP
virus-infected  	virus-infected  	 JJ	I-NP
patients  	patients  	 NNS	I-NP
receiving  	receiving  	 VBG	O
antiretroviral  	antiretroviral  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
has  	has  	 VBZ	O
subsequently  	subsequently  	 RB	O
been  	been  	 VBN	O
described  	described  	 VBN	O
in  	in  	 IN	O
solid-organ  	solid-organ  	 JJ	B-NP
transplant  	transplant  	 NN	I-NP
recipients 	recipients 	 NNS	I-NP
,  	,  	 ,	O
neutropenic  	neutropenic  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
women  	women  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
postpartum  	postpartum  	 JJ	B-NP
period 	period 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
recipients  	recipients  	 NNS	O
of  	of  	 IN	O
tumor  	tumor  	 NN	B-NP
necrosis  	necrosis  	 VBZ	O
factor-α  	factor-α  	 JJ	B-NP
inhibitor  	inhibitor  	 JJ	I-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
these  	these  	 DT	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
recovery  	recovery  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
host 	host 	 NN	O
's  	's  	 POS	O
immunity  	immunity  	 NN	O
during  	during  	 IN	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
initial  	initial  	 JJ	O
infection  	infection  	 NN	B-NP
results  	results  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
powerful  	powerful  	 JJ	O
proinflammatory  	proinflammatory  	 JJ	B-NP
environment  	environment  	 NN	I-NP
that  	that  	 IN	O
overshoots  	overshoots  	 NN	O
and  	and  	 CC	O
leads  	leads  	 VBZ	O
to  	to  	 TO	O
host  	host  	 VB	O
damage 	damage 	 NN	O
.  	.  	 .	O
Optimal  	Optimal  	 JJ	B-NP
management  	management  	 NN	I-NP
of  	of  	 IN	I-NP
IRS  	IRS  	 NNP	I-NP
has  	has  	 VBZ	O
not  	not  	 RB	O
been  	been  	 VBN	O
established  	established  	 VBN	O
at  	at  	 IN	O
present 	present 	 JJ	O
,  	,  	 ,	O
but  	but  	 CC	O
often  	often  	 RB	O
involves  	involves  	 VBZ	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
corticosteroid  	corticosteroid  	 NN	B-NP
or  	or  	 CC	O
other  	other  	 JJ	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
compounds 	compounds 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
article  	article  	 NN	O
uses  	uses  	 VBZ	O
a  	a  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
patient  	patient  	 JJ	O
cases  	cases  	 NNS	O
to  	to  	 TO	O
explore  	explore  	 VB	O
the  	the  	 DT	O
intricacies  	intricacies  	 NN	O
of  	of  	 IN	O
diagnosing  	diagnosing  	 NN	O
and  	and  	 CC	O
managing  	managing  	 VBG	O
a  	a  	 DT	O
patient  	patient  	 NN	O
with  	with  	 IN	O
IRS 	IRS 	 NNP	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
other  	other  	 JJ	O
extreme 	extreme 	 NN	O
,  	,  	 ,	O
namely  	namely  	 JJ	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
are  	are  	 VBP	O
so  	so  	 RB	O
immunocompromised  	immunocompromised  	 VBN	O
without  	without  	 IN	O
immune  	immune  	 JJ	O
recovery  	recovery  	 NN	O
that  	that  	 IN	O
they  	they  	 PRP	O
essentially  	essentially  	 RB	O
become  	become  	 VB	O
breeding  	breeding  	 VBG	B-NP
grounds  	grounds  	 NNS	I-NP
for  	for  	 IN	O
a  	a  	 DT	O
wide  	wide  	 JJ	O
range  	range  	 NN	O
of  	of  	 IN	O
opportunistic  	opportunistic  	 JJ	B-NP
pathogens 	pathogens 	 NN	I-NP
,  	,  	 ,	O
often  	often  	 RB	O
simultaneously 	simultaneously 	 RB	O
.  	.  	 .	O
